TSXV:APC.H - Post by User
Post by
Goldnboy1on Oct 04, 2021 2:08am
215 Views
Post# 33959650
Covid Therapy
Covid Therapy New presentation on website suggests company is pursuing the development of a drug that competes or exceeds the abilities of Remdesevir.
Stated pretty clearly in the presentation. Here is the link.
Six compound families rationally designed. Sounds like the company has isolated six opportunities in silico. Better than having just one shot at it! We have six shots at it!
Expecting the company to move rapidly into in vivo/in vitro animal studies once compounds fully synthesized.
Also hearing the company and the NIH have been in touch. Would be amazing to get some non dilutive funding. Remember the company is technically American based but Canadian majority owned
Stock touching long term moving average could see a solid turn from here this week. I'm hearing news floodgate about to burst soon.
https://www.advancedproteome.com/wp-content/uploads/2021/09/SARS-CoV-2-Mpro.pdf